首页> 外国专利> 1 Novel synthetic antimicrobial hybrid peptide derived from Ribosomal Protein L1 of Helicobacter pylori and use thereof

1 Novel synthetic antimicrobial hybrid peptide derived from Ribosomal Protein L1 of Helicobacter pylori and use thereof

机译:1来源于幽门螺杆菌核糖体蛋白L1的新型合成抗菌杂合肽及其用途

摘要

PURPOSE: Provided is a novel synthetic antibacterial hybrid peptide derived from Ribosomal Protein L1 of Helicobacter pylori and the use thereof. The synthetic antibacterial hybrid peptide has excellent antifungal and antibacterial activities without toxicity to remove bacteria which show antibiotics resistance. CONSTITUTION: The synthetic antimicrobial hybrid peptide is manufactured by hybridizing the amino terminal region of RPL1(ribosomal protein L1) protein produced by Helicobacter pylori with the amino terminal regions of melittin and magainin. The amino terminal region of RPL1(ribosomal protein L1) protein is represented by the SEQ ID NO:1, and the amino terminal regions of melittin and magainin are represented by SEQ ID NO:2 and SEQ ID NO:3 respectively.
机译:目的:提供一种新型的来源于幽门螺杆菌的核糖体蛋白L1的合成抗菌杂合肽及其用途。合成的抗菌杂合肽具有优异的抗真菌和抗菌活性,并且对去除表现出抗生素抗性的细菌没有毒性。组成:合成的抗菌素杂合肽是通过将幽门螺杆菌产生的RPL1(核糖体蛋白L1)蛋白的氨基末端区域与蜂毒肽和麦角菌素的氨基末端区域杂交而制得的。 RPL1(核糖体蛋白L1)蛋白的氨基末端区域由SEQ ID NO:1表示,蜂毒肽和麦胶蛋白的氨基末端区域分别由SEQ ID NO:2和SEQ ID NO:3表示。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号